
José Fachi, PhD
@zefachi
Scientist studying mucosal immunity and gut microbiota. @Pewtrusts Latin American Fellow at @TheColonnaLab @wusm_pathology 🇺🇲🇧🇷
ID: 1358815434976419840
08-02-2021 16:30:32
65 Tweet
208 Followers
297 Following


Excited to share our latest review describing Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation The Colonna Lab - Immunological Reviews - Wiley Online Library onlinelibrary.wiley.com/doi/full/10.11…

NEW Review of the molecular mechanisms by which short-chain fatty acids - butyrate, propionate and acetate - link diet, microbiota and immunity bit.ly/49jfypn by Lizzie Mann UoM Ying Ka Lam & Holm Uhlig


Deficiency of IL-22–binding protein enhances the ability of the gut microbiota to protect against enteric pathogens The Colonna Lab Blanda Di Luccia José Fachi, PhD pnas.org/doi/10.1073/pn…

#WeekendRead! The Colonna Lab & #IL22 are on🔥! Siyan Cao "Stewart", MD PhD &co show Journal of Clinical Investigation that ER stress control IL22 in ILC3s in #IBD jci.org/articles/view/…! Blanda Di Luccia José Fachi, PhD &co show PNASNews that lacking IL22BP reshape the #microbiota against gut infection pnas.org/doi/10.1073/pn…

📢Come join us this Thursday! We'll discuss fellowship applications (both grad and postdoc) as an #InternationalTrainee in the US. If you are transitioning to a postdoc, this talk may help you prepare ahead ;) Yale Cell Biology Yale Neuroscience Yale Postdoctoral Association (YPA) 📅05/16 ⏲️3pm



Happy to share our new study showing IL-22BP deficiency enhances gut microbiota's defense against infections. This boosts acetate production by Il22ra2–/–associated microbiota, suggesting IL-22BP as a therapeutic target. Led by José Fachi, PhD and Blanda Di Luccia pnas.org/doi/10.1073/pn…

Our new paper led by Tihana Trsan, collaboration with Xavier Lab, investigating the link between FGFR1OP and Crohn’s disease. Deletion of FGFR1OP, a centrosomal protein, in mouse gut cells disrupts crypt architecture, causing inflammation and fatality cell.com/developmental-…

.Siyan Cao "Stewart", MD PhD et al. from the The Colonna Lab Test Account show that the IRE1α/XBP1 pathway sustains cytokine responses of group 3 innate lymphoid cells in inflammatory bowel disease: buff.ly/3W7heyJ #Gastroenterology #Immunology



Our work by Fachi et al. José Fachi, PhD is out in PNAS! We show how NKp46+ ILC3s boost early gut defense against C. difficile infection by producing GM-CSF to support neutrophils. A potential path to new CDI treatments! pnas.org/doi/10.1073/pn…


A study from Victora Lab and DM in Science Magazine reveals how immune cells in the gut distinguish between food and harmful pathogens, shedding light on the origins of both food allergies and intestinal diseases. #RockefellerScience bit.ly/4hyS18b

Fiber fine tunes MHC to impact CDI Low-fiber diet worsens C. difficile infection by increasing MHC-II in colonic epithelium, promoting pathogenic CD4+IELs. Acetate from fibers enhances ILC3-derived IL-22, suppressing MHC-II expression The Colonna Lab cell.com/cell-host-micr…


Excited to share that our work is featured on the cover of the latest issue of Cell Host & Microbe! Check it out! The Colonna Lab Marco Vinolo The Pew Trusts #Microbiology #Immunology #CellHostMicrobe




José Fachi, PhD talk is now on YouTube! 🎙️ José Luis Fachi (Washington University in St. Louis l) 📣 NKp46+ ILC3s promote early neutrophil defense against Clostridioides difficile infection through GM-CSF secretion (PNAS, 20254) youtu.be/wEaptMNfNw0